Back to search
FDAFDA · Food and drugs·Recall number D-0651-2017

Doxercalciferol Capsules 0.5mcg, 50 count bottles, Rx, only, Manufactured by Cipla Limited Kurkumbh, Maharashtra, India, Manufactured for West-Ward, Pharmaceuticals, Corp., Eatontown, NJ -- NDC 0054-0338-19

Published April 19, 2017 · Recall initiated: April 4, 2017

Summary

FDA records drug Class III recall D-0651-2017, published April 19, 2017 and initiated April 4, 2017. Recalling firm: West-Ward Columbus, Inc.; Status: Terminated; Reported quantity: 100 bottles; Lot: Lot KB60707, 10/31/2018. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Tablet/Capsule Specifications; during an internal inspection, capsules were found with illegible print.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
West-Ward Columbus, Inc.
Distributor
The recalled product was distributed to the following state: OH. There are no Canada accounts for this recall. There are no Mexico accounts for this recall. There are no government accounts for this recall.
Lot
Lot KB60707, 10/31/2018
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Doxercalciferol Capsules 0.5mcg, 50 count bottles, Rx, only, Manufactured by Cipla Limited Kurkumbh, Maharashtra, India, Manufactured for West-Ward, Pharmaceuticals, Corp., Eatontown, NJ -- NDC 0054-0338-19 recalled?

Yes. FDA published recall D-0651-2017 on April 19, 2017. Reported hazard: Failed Tablet/Capsule Specifications; during an internal inspection, capsules were found with illegible print.

What should I do if I have this product?

Voluntary: Firm initiated · Letter